NPS Pharma Says Gattex Meeting October 16th
NPS Pharmaceuticals (NASDAQ: NPSP) today announced that the U.S. Food and Drug Administration (FDA) has notified the Company that its New Drug Application (NDA) for Gattex® (teduglutide) will be discussed at the Gastrointestinal Drugs Advisory Committee meeting scheduled for October 16, 2012. The Prescription Drug User Fee Act (PDUFA) date for completion of review by the FDA is December 30, 2012.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.